Movement Disorders

Displaying 1 - 17 out of 17 guidelines found

  1. Comprehensive Systematic Review Summary: Treatment of Cerebellar Motor Dysfunction and Ataxia

    February 2018

    Current systematic review. Endorsed by the A-TCP Children's Project.

  2. Practice Guideline Summary: Treatment of Restless Legs Syndrome in Adults

    November 2016

    Current guideline.

  3. Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache

    April 2016

    Current guideline. Endorsed by the American Association of Neuromuscular & Electrodiagnostic Medicine and by the American Society of Plastic Surgeons.

  4. Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders

    April 2014

    Current systematic review. Endorsed by the American Autonomic Society, the American Epilepsy Society, the Consortium of Multiple Sclerosis Centers, the International Organization of Multiple Sclerosis Nurses, and the International Rett Syndrome Foundation.

  5. Treatment of Tardive Syndromes

    July 2013

    Current guideline. Reaffirmed on July 16, 2016.

  6. Pharmacologic Treatment of Chorea in Huntington Disease

    August 2012

    Update in progress. Reaffirmed on July 18, 2015.

  7. Recommendations for the Predictive Genetic Test in Huntington's Disease

    May 2012

    Affirmed by the AAN on January 14, 2014.

  8. Update: Treatment of Essential Tremor

    October 2011

    Current guideline. Reaffirmed on April 30, 2014. Endorsed by the International Essential Tremor Foundation.

  9. Treatment of Nonmotor Symptoms of Parkinson Disease

    March 2010

    Current guideline. Endorsed by the American Academy of Sleep Medicine.

  10. Botulinum Neurotoxin for the Treatment of Movement Disorders

    May 2008

    Under update. Endorsed by the American Association of Neuromuscular & Electrodiagnostic Medicine and the American Academy of Physical Medicine & Rehabilitation.

  11. Neuroprotective Strategies and Alternative Therapies for Parkinson Disease

    April 2006

    Update in progress. Reaffirmed on October 17, 2009, and July 13, 2013.

  12. Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesias

    April 2006

    Retired by the AAN Institute Board of Directors on February 27, 2018.

  13. Diagnosis and Prognosis of New Onset Parkinson Disease

    April 2006

    Retired by the AAN Institute Board of Directors on March 9, 2016.

  14. Evaluation and Treatment of Depression, Psychosis, and Dementia in Parkinson Disease

    April 2006

    Retired by the AAN Institute Board of Directors on February 27, 2018.

  15. Therapies for Essential Tremor

    June 2005

    Updated by "Evidence-based Guideline Update: Treatment of Essential Tremor" (June 2011).

  16. Diagnostic Assessment of the Child with Cerebral Palsy

    March 2004

    Update in progress. Reaffirmed on July 21, 2007.

  17. Initiation of Treatment for Parkinson's Disease

    January 2002

    Reaffirmed on October 15, 2005. Replaces "Practice Parameters: Initial Therapy of Parkinson's Disease (Summary Statement)" (July 1993).

Questions?

Email guidelines@aan.com

Call (800) 879-1960 or (612) 928-6000 (international)

Top

Footer